Topical capsaicin for the treatment of acute lipodermatosclerosis and lobular panniculitis

Journal of Dermatological Treatment

Volumn 16, Issue 3, 2005, Pages 178-180

  Yosipovitch, Gil ^a,b   Mengesha, Y ^a,b   Facliaru, D ^d   David, M ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Kupat Holim Clalit Rishon Lezion   (Israel)

Author keywords

Acute lipodermatosclerosis; Capsaicin; Lobular panniculitis

Indexed keywords

CAPSAICIN; EMLA; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; POTASSIUM IODIDE; PREDNISONE; TRIAMCINOLONE;

ACUTE DISEASE; ACUTE LIPODERMATOSCLEROSIS; ADULT; AGED; ARTICLE; BURN; CASE REPORT; CELLULITIS; COMPRESSION THERAPY; FEMALE; HUMAN; LIPODERMATOSCLEROSIS; LOBULAR PANNICULITIS; PANNICULITIS; PRIORITY JOURNAL; SIDE EFFECT; VEIN INSUFFICIENCY;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADULT; AGED; CAPSAICIN; FEMALE; HUMANS; LEG DERMATOSES; LIPOMATOSIS; PANNICULITIS; PREGNANCY; SCLERODERMA, LOCALIZED; TREATMENT OUTCOME;

EID: 25444492042     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630510041079     Document Type: Article

References (16)

1. Kirsner RS, Pardes JB, Eaglestein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993;28:623-7.
2. Greenberg AS, Hsan A, Montalvo BM, Falabella A, Falanga V. Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol. 1996;35:566-8.
3. Jorrizo J, White WL, Zanolli MD, Greer KE, Solomon AR, Jetton RL. Sclerosing panniculitis: a clinicopathologic assessment. Arch Dermatol. 1991;127:554-8.
4. Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol. 1995;32:254-6.
5. McMullin GM, Watkin GT, Coleridge Smith PD, Scurr JH. Efficacy of fibrinolytic enhancement with stanozolol in treatment of venous insufficiency. Aust N Z J Surg. 1991;61:306-9.
6. Physcians Desk Reference, 52nd edn. Thompson, 1998: 2595,.
7. Lynn B. Capsaicin: actions on nociceptive C-fibres and therapeutic potential. Pain. 1990;41:61-9.
8. Tominack RL, Spyker DA. Capsaicum and capsaicin a review: case report of the use of hot peppers in child abuse. J Toxicol Clin Toxicol. 1987;25:591-601.
9. Yang JM, Tang CS, Yu KL, Yang YC, Chang WC, Chen IJ. Sodium nonivamide acetate; a non pungently antinociceptive capsaicin derivative with unusual anti inflammatory properties. Gen Pharmacol. 1996;27:141-50.
10. Wang JP, Hsu MF, Hsu TP, Teng CM. Antihemostatic and antithrombotic effects of capsaicin in comparison with aspirin and indomethacin. Thromb Res. 1985;37:669-79.
11. Visudhiphan S, Poolsuppasit S, Piboonukrintr O, Tumaling S. The relationship between the high fibrinolytic activity and daily capsaicum ingestion in Thais. Am J Clin Nutr. 1982;35:1452-8.
12. Fanciullacci M, Fedi S, Alessandri M, Pietrini. Substance P induced fibrinolysis in the forearm of healthy volunteers. Experientia. 1993;49:242-4.
13. Newby DE, Wright RA, Dawson P, Ludlam CA, Boon NA, Fox KA, et al. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res. 1998;38:485-92.
14. Baluk P. Neurogenic inflammation in the skin and airways. J Invest Dermatol. 1997;2:76-81.
15. Lindsey KQ, Caughman WS, Olerud J, Bunnett NW, Armstrong CA, Ansel JC. Neural regulation of endothelial cell-mediated inflammation. J Invest Dermatol Symp Proc. 2000;5:74-8.
16. Yosipovitch G, Maibach HI, Rowbotham M. Effect of EMLA pretreatment on capsaicin-induced burning and hyperalgesia. Acta Derm Venereol. 1999;79:118-21.